A novel method to address the association between received dose intensity and survival outcome: benefits of approaching treatment intensification at a more individualised level in a trial of the European Osteosarcoma Intergroup. (2019)

First Author: Lancia C


No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00280-019-03797-3

PubMed Identifier: 30879111

Publication URI: http://europepmc.org/abstract/MED/30879111

Type: Journal Article/Review

Volume: 83

Parent Publication: Cancer chemotherapy and pharmacology

Issue: 5

ISSN: 0344-5704